Medical Device Firm Remedy Lists on South Korea's Kosdaq on July 13 Amid 1701:1 Subscription Ratio
According to Seoul Economy, medical device manufacturer Remedy debuted on South Korea's Kosdaq market on July 13 with an offer price of 20,700 Korean won, at the upper end of its target range. The stock recorded a 1701:1 subscription ratio during public bidding from July 1-2, with institutional
GateNews·07-12 21:43
